- Home
- Publications
- Publication Search
- Publication Details
Title
PD-L1/PD-1 Axis in Glioblastoma Multiforme
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 21, Pages 5347
Publisher
MDPI AG
Online
2019-10-28
DOI
10.3390/ijms20215347
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Obesity as a tumour development triggering factor
- (2019) Agnieszka Budny et al. ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE
- Serum iron, Magnesium, Copper, and Manganese Levels in Alcoholism: A Systematic Review
- (2019) Cezary Grochowski et al. MOLECULES
- Neural stem cell therapy - brief review
- (2018) Cezary Grochowski et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Antibodies to watch in 2018
- (2018) Hélène Kaplon et al. mAbs
- Monoclonal antibodies in cancer immunotherapy
- (2018) Ilgin Kimiz-Gebologlu et al. MOLECULAR BIOLOGY REPORTS
- EGFR and EGFRvIII Promote Angiogenesis and Cell Invasion in Glioblastoma: Combination Therapies for an Effective Treatment
- (2017) Stefanie Keller et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- OS09.5 Synergistic effect of reirradiation and PD-1 inhibitors in recurrent high-grade gliomas
- (2017) F. M. Iwamoto et al. NEURO-ONCOLOGY
- Autocrine activation of the IFN signaling pathway may promote immune escape in glioblastoma
- (2017) Manuela Silginer et al. NEURO-ONCOLOGY
- OS10.3 Randomized Phase 3 Study Evaluating the Efficacy and Safety of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: CheckMate 143
- (2017) D. A. Reardon et al. NEURO-ONCOLOGY
- Ultra high field TOF-MRA: A method to visualize small cerebral vessels. 7 T TOF-MRA sequence parameters on different MRI scanners – Literature review
- (2017) Cezary Grochowski et al. Neurologia i Neurochirurgia Polska
- Relationship between expression of PD-L1 and tumor angiogenesis, proliferation, and invasion in glioma
- (2017) Song Xue et al. Oncotarget
- Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
- (2017) Angel Garcia-Diaz et al. Cell Reports
- Tumor microenvironment in treatment of glioma
- (2017) Guijie Li et al. Open Medicine
- Cancer Treatment with Anti-PD-1/PD-L1 Agents: Is PD-L1 Expression a Biomarker for Patient Selection?
- (2016) Lucia Festino et al. DRUGS
- MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade
- (2016) Peter J.R. Ebert et al. IMMUNITY
- PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer's disease
- (2016) Kuti Baruch et al. NATURE MEDICINE
- ATIM-15. A PHASE I TRIAL OF HYPOFRACTIONATED STEREOTACTIC IRRADIATION (HFSRT) WITH PEMBROLIZUMAB AND BEVACIZUMAB IN patients with recurrent high grade gliomas
- (2016) Solmaz Sahebjam et al. NEURO-ONCOLOGY
- Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy
- (2016) Ju Yeon Lee et al. Nature Communications
- Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations
- (2016) Daniel Sanghoon Shin et al. Cancer Discovery
- Glioblastoma Stem-Like Cells: Characteristics, Microenvironment, and Therapy
- (2016) Yang Yi et al. Frontiers in Pharmacology
- Targeting the MAPK and PI3K pathways in combination with PD1 blockade in melanoma
- (2016) Marcel A. Deken et al. OncoImmunology
- Clinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma?
- (2015) Matthias Preusser et al. CLINICAL NEUROPATHOLOGY
- Immunotherapy for non-small cell lung cancer: current concepts and clinical trials
- (2015) Marissa Mayor et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Heat shock protein vaccines against glioblastoma: from bench to bedside
- (2015) Leonel Ampie et al. JOURNAL OF NEURO-ONCOLOGY
- Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial
- (2015) Naiyer A Rizvi et al. LANCET ONCOLOGY
- Mechanisms of action of therapeutic antibodies for cancer
- (2015) J.M. Redman et al. MOLECULAR IMMUNOLOGY
- Structural and functional features of central nervous system lymphatic vessels
- (2015) Antoine Louveau et al. NATURE
- PD-L1 expression and prognostic impact in glioblastoma
- (2015) Edjah K. Nduom et al. NEURO-ONCOLOGY
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Modulation of cerebral endothelial cell function by TGF-β in glioblastoma: VEGF-dependent angiogenesis versus endothelial mesenchymal transition
- (2015) Shanmugarajan Krishnan et al. Oncotarget
- Treatment of Elderly Patients With Glioblastoma
- (2015) Oren J. Zarnett et al. JAMA Neurology
- Immunotherapeutic Advancements for Glioblastoma
- (2015) Leonel Ampie et al. Frontiers in Oncology
- The PD-1/B7-H1 Pathway Modulates the Natural Killer Cells versus Mouse Glioma Stem Cells
- (2015) Bo Yuan Huang et al. PLoS One
- Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
- (2014) J. M. Taube et al. CLINICAL CANCER RESEARCH
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- Anti-PD-1 Blockade and Stereotactic Radiation Produce Long-Term Survival in Mice With Intracranial Gliomas
- (2013) Jing Zeng et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Structure and Interactions of the Human Programmed Cell Death 1 Receptor
- (2013) Xiaoxiao Cheng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Toll like receptor (TLR)-induced differential expression of microRNAs (MiRs) and immune response against infection: A systematic review
- (2013) Seyed Hossein Aalaei-andabili et al. JOURNAL OF INFECTION
- Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors
- (2013) E. A. Akbay et al. Cancer Discovery
- Inverse Association between Programmed Death Ligand 1 and Genes in the VEGF Pathway in Primary Clear Cell Renal Cell Carcinoma
- (2013) R. W. Joseph et al. Cancer Immunology Research
- Targeting EGFR for Treatment of Glioblastoma: Molecular Basis to Overcome Resistance
- (2012) T. E. Taylor et al. CURRENT CANCER DRUG TARGETS
- The regulation of cysteine cathepsins and cystatins in human gliomas
- (2012) Boris Gole et al. INTERNATIONAL JOURNAL OF CANCER
- Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2
- (2012) Tadashi Yokosuka et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The disturbed blood–brain barrier in human glioblastoma
- (2012) Hartwig Wolburg et al. MOLECULAR ASPECTS OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cannabinoids inhibit peptidoglycan-induced phosphorylation of NF-κB and cell growth in U87MG human malignant glioma cells
- (2012) RYOSUKE ECHIGO et al. ONCOLOGY REPORTS
- Functional cooperativity by direct interaction between PAK4 and MMP-2 in the regulation of anoikis resistance, migration and invasion in glioma
- (2012) D Kesanakurti et al. Cell Death & Disease
- Cancer Immunotherapy Comes of Age
- (2011) Suzanne L. Topalian et al. JOURNAL OF CLINICAL ONCOLOGY
- Epidermal growth factor induces matrix metalloproteinase-1 (MMP-1) expression and invasion in glioma cell lines via the MAPK pathway
- (2011) M. Anand et al. JOURNAL OF NEURO-ONCOLOGY
- EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway
- (2011) R Bonavia et al. ONCOGENE
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Cetuximab Insufficiently Inhibits Glioma Cell Growth Due to Persistent EGFR Downstream Signaling
- (2010) Benedikte Hasselbalch et al. CANCER INVESTIGATION
- Human MxA Protein: An Interferon-Induced Dynamin-Like GTPase with Broad Antiviral Activity
- (2010) Otto Haller et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Cyclooxygenase-2 Is a Novel Transcriptional Target of the Nuclear EGFR-STAT3 and EGFRvIII-STAT3 Signaling Axes
- (2010) H.-W. Lo et al. MOLECULAR CANCER RESEARCH
- The Presence of IL-17A and T Helper 17 Cells in Experimental Mouse Brain Tumors and Human Glioma
- (2010) Derek A. Wainwright et al. PLoS One
- Molecular Mechanisms Underlying Effects of Epidermal Growth Factor Receptor Inhibition on Invasion, Proliferation, and Angiogenesis in Experimental Glioma
- (2009) J.-S. Guillamo et al. CLINICAL CANCER RESEARCH
- The EGFRvIII variant in glioblastoma multiforme
- (2009) Hui K. Gan et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Therapeutic Inhibition of the Epidermal Growth Factor Receptor in High-Grade Gliomas: Where Do We Stand?
- (2009) G. Karpel-Massler et al. MOLECULAR CANCER RESEARCH
- Glioblastoma-Derived Mechanisms of Systemic Immunosuppression
- (2009) Allen Waziri NEUROSURGERY CLINICS OF NORTH AMERICA
- Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesis
- (2009) Haihao Zhu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TLR-4, IL-1R and TNF-R signaling to NF-κB: variations on a common theme
- (2008) L. Verstrepen et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Expression of TLR9 within human glioblastoma
- (2008) Yuxia Meng et al. JOURNAL OF NEURO-ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started